These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18511044)

  • 1. Parkinson patient fibroblasts show increased alpha-synuclein expression.
    Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
    Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
    Hoepken HH; Gispert S; Morales B; Wingerter O; Del Turco D; Mülsch A; Nussbaum RL; Müller K; Dröse S; Brandt U; Deller T; Wirth B; Kudin AP; Kunz WS; Auburger G
    Neurobiol Dis; 2007 Feb; 25(2):401-11. PubMed ID: 17141510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.
    Torres-Odio S; Key J; Hoepken HH; Canet-Pons J; Valek L; Roller B; Walter M; Morales-Gordo B; Meierhofer D; Harter PN; Mittelbronn M; Tegeder I; Gispert S; Auburger G
    J Neuroinflammation; 2017 Aug; 14(1):154. PubMed ID: 28768533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
    Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
    Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N; Melamed E; Offen D
    Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
    Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
    FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
    Zhang Y; Dawson VL; Dawson TM
    Neurobiol Dis; 2000 Aug; 7(4):240-50. PubMed ID: 10964596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease.
    Prigione A; Piazza F; Brighina L; Begni B; Galbussera A; Difrancesco JC; Andreoni S; Piolti R; Ferrarese C
    Neurosci Lett; 2010 Jun; 477(1):6-10. PubMed ID: 20399833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease.
    Abahuni N; Gispert S; Bauer P; Riess O; Krüger R; Becker T; Auburger G
    Neurosci Lett; 2007 Mar; 414(2):126-9. PubMed ID: 17267121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
    Lesage S; Anheim M; Letournel F; Bousset L; Honoré A; Rozas N; Pieri L; Madiona K; Dürr A; Melki R; Verny C; Brice A;
    Ann Neurol; 2013 Apr; 73(4):459-71. PubMed ID: 23526723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in skin fibroblasts from a Parkinson's disease patient with an alpha-synuclein triplication.
    Mak SK; Tewari D; Tetrud JW; Langston JW; Schüle B
    J Parkinsons Dis; 2011; 1(2):175-83. PubMed ID: 23934919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease.
    Voutsinas GE; Stavrou EF; Karousos G; Dasoula A; Papachatzopoulou A; Syrrou M; Verkerk AJ; van der Spek P; Patrinos GP; Stöger R; Athanassiadou A
    Hum Mutat; 2010 Jun; 31(6):685-91. PubMed ID: 20340137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
    Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
    Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.